FDA okays Eli Lilly’s new weight-loss pill, expanding options for millions
The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants
The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
The campaign highlights a straightforward, achievable approach to health, proving that supporting your wellness doesn’t have to be complicated
The Trust’s shift from single-use compostable cups to a reusable system was driven by the need to reduce environmental impact and control long-term costs
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
The company plans to submit the vaccine for regulatory review
KeyCi’s dermatologically tested lineup emphasizes clean formulations—vegan, cruelty-free, alcohol-free, and paraben-free—while being backed by pharmaceutical-grade research and FDA approval
India faces a significant and growing burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease
Subscribe To Our Newsletter & Stay Updated